Why the study?
Do selective serotonin reuptake inhibitors (SSRIs) increase the risk of cerebrovascular adverse reactions?
Do selective serotonin reuptake inhibitors (SSRIs) increase the risk of cerebrovascular adverse reactions?
This review indicates that SSRIs are generally safe regarding cerebrovascular risk, though pharmacovigilance is recommended in high-risk populations and when combined with other serotonergic drugs.
No takes yet. Share an insight, caveat, or question.
Supports routine SSRI prescribing with minimal cerebrovascular concern; confirms safety while extending evidence for poststroke and high-risk monitoring.
Rajamannar Ramasubbu (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: